Crystal Pharmatech Expands Leadership Team

Crystal Pharmatech, INC is honored to announce it has hired Dr. Rositza Petrova to Head up US Research and Development efforts. Rosie will report directly to the Head of US Operations and work closely with other highly experienced Crystal Pharmatech solid-state chemists including Dr. Robert Wenslow, Dr. Gregory Stephenson and Dr. Paul Luner in nurturing a scientific team dedicated to providing clients' unrivaled high quality solutions to their pharmaceutical development issues.

Before joining Crystal Pharmatech, Dr. Petrova spent over 15 years at Merck & Co. with increasing responsibilities.  She is a true solid-state expert with extensive experience in cross-functional development teams managing all aspects of solid state characterization.  This includes early and clinical formulation development, API isolation and crystal form selection.  Her people management and collaboration skills combined with her high technical expertise will make for a perfect fit in Crystal Pharmatechs' approach to project management and union.

Join us in welcoming Rosie to our family.

Founded in July 2010, Crystal Pharmatech is a global，technology-driven research organization with labs in China (Suzhou, which is the company's headquarters) and US (New Jersey) that helps pharmaceutical companies develop new drugs efficiently and effectively.  It focuses on materials science and engineering for drug development and also offers services from solid form screening and evaluation to processing of active pharmaceutical ingredients and formulations. With a leading platform in solid form research, Crystal Pharmatech has built successful business relationships with over 300 pharmaceutical companies around the world and become a preferred partner in its field of services.